Alzheimer's Disease: Treatment Strategies and Their Limitations.
Passeri E, Elkhoury K, Morsink M, Broersen K, Linder M, Tamayol A, Malaplate C, Yen FT, Arab-Tehrany E. · 2022
Read Alzheimer's Disease: Treatment Strategies and Their Limitations. by Passeri E, Elkhoury K, Morsink M, Broersen K, Linder M, Tamayol A, Malaplate C, Yen FT, Arab-Tehrany E. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9697769.txt.
Description
Passeri and co-authors review treatment strategies for Alzheimer's disease and the limits each one faces. The disease is the most common nerve wasting illness worldwide. Decades of drug work have brought no cure at all. Current drugs ease symptoms but do not change the course.
The review sets out the disease stages and risk factors first. It splits risks into those that can change and those that cannot. Study models used in the field get a survey next. Prevention is framed as the best plan at this time. Good habits and early steps can slow the disease path. Getting drugs into the brain is the core hard problem. The blood-brain barrier blocks most compounds from entry. Soft nanoparticles draw the authors' strongest praise here. Nanoliposomes and exosomes can cross and target brain tissue. Nose based dosing is a further route they weigh.
Catalog record
| CREATOR | Passeri E, Elkhoury K, Morsink M, Broersen K, Linder M, Tamayol A, Malaplate C, Yen FT, Arab-Tehrany E. |
|---|---|
| YEAR | 2022 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 133 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |